You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

GSK’s primary therapy areas

Respiratory

Respiratory

GSK UK information about our respiratory portfolio, as well as resources and latest news.

Vaccines

Vaccines

GSK UK information about our vaccines portfolio, as well as resources and latest news.

 

GSK’s other therapy areas

Allergy

Allergy

GSK UK information about our allergy portfolio, as well as resources and latest news.

Anaesthetics

Anaesthetics

GSK UK information about our anaesthetics portfolio, as well as resources and latest news.

Anti-infectives

Anti-infectives

GSK UK information about our anti-infectives portfolio, as well as resources and latest news.

Cardiovascular

Cardiovascular

GSK UK information about our cardiovascular portfolio, as well as resources and latest news.

Dermatology

Dermatology

GSK UK information about our Stiefel dermatology products.

Gastroenterology

Gastroenterology

GSK UK information about our gastroenterology portfolio, as well as resources and latest news.

Influenza

Influenza

GSK UK information about our influenza portfolio, as well as resources and latest news.

Musculoskeletal

Musculoskeletal

GSK UK information about our musculoskeletal portfolio, as well as resources and latest news.

Neurology

Neurology

GSK UK information about our neurology portfolio, as well as resources and latest news.

Urology

Urology

GSK UK information about our urology portfolio, as well as resources and latest news.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

M.C: 07 December 2015. UK/COM/0106/15s